Titre:
  • Trastuzumab-associated cardiac adverse effects in the herceptin adjuvant trial.
Auteur:Suter, T.; Procter, Marion; van Veldhuisen, Dirk J; Muscholl, Michael; Carlomagno, Chiara; Perren, Thimothy J.; Passalacqua, Rodolfo; Bighin, Claudia; Klijn, J G; Ageev, Fail T; Hitre, Erika; Groetz, Juergen; Iwata, Hiroji; Knap, Malgorzata; Gnant, Michael; Muehlbauer, Susanne; Spence, Alison; Gelber, R D; Bergh, J.; Piccart-Gebhart, Martine
Informations sur la publication:Journal of clinical oncology, 25, 25, page (3859-3865)
Statut de publication:Publié, 2007-09
Sujet CREF:Sciences bio-médicales et agricoles
MeSH keywords:Antibodies, Monoclonal -- administration & dosage
Antibodies, Monoclonal -- adverse effects
Antineoplastic Agents -- adverse effects
Breast Neoplasms -- drug therapy
Cardiovascular Diseases -- chemically induced
Disease-Free Survival
Female
Heart Failure -- chemically induced
Humans
Middle Aged
Receptor, erbB-2 -- metabolism
Note générale:Clinical Trial, Phase III
Journal Article
Multicenter Study
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langue:Anglais
Identificateurs:urn:issn:0732-183X
info:doi/10.1200/JCO.2006.09.1611
info:pii/JCO.2006.09.1611
info:pmid/17646669